AM
BMY icon

AGF Management’s Bristol-Myers Squibb BMY Stock Holding History

AGF Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.1M Sell
512,888
-60,511
-11% -$3.53M 0.14% 130
2025
Q4 		$30.9M Sell
573,399
-9,910
-2% -$477K 0.13% 126
2025
Q3 		$26.3M Sell
583,309
-4,431
-0.8% -$207K 0.12% 136
2025
Q2 		$27.2M Buy
587,740
+8,021
+1% +$394K 0.12% 135
2025
Q1 		$35.4M Sell
579,719
-27,345
-5% -$1.59M 0.19% 123
2024
Q4 		$34.3M Buy
607,064
+45,901
+8% +$2.56M 0.17% 126
2024
Q3 		$29M Buy
561,163
+4,830
+0.9% +$227K 0.15% 139
2024
Q2 		$23.1M Sell
556,333
-21,187
-4% -$948K 0.13% 140
2024
Q1 		$31.3M Sell
577,520
-17,400
-3% -$886K 0.17% 137
2023
Q4 		$30.5M Buy
594,920
+7,904
+1% +$415K 0.18% 132
2023
Q3 		$34.1M Sell
587,016
-14,025
-2% -$859K 0.24% 115
2023
Q2 		$38.4M Sell
601,041
-14,583
-2% -$978K 0.28% 105
2023
Q1 		$42.7M Sell
615,624
-7,948
-1% -$561K 0.29% 102
2022
Q4 		$44.9M Buy
+623,572
New +$47M 0.33% 90

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AGF Management's BMY Position: Q1 2026 in Review

AGF Management reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q1 2026, selling an estimated $3.53M and leaving 512,888 shares worth $31.1M. The position accounts for 0.14% of the portfolio, ranked #130.

AGF Management first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $44.9M in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • AGF Management held 512,888 shares of Bristol-Myers Squibb worth $31.1M as of Q1 2026.
  • AGF Management sold 60,511 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.53M.
  • Bristol-Myers Squibb made up 0.14% of AGF Management's portfolio in Q1 2026, its #130 holding.
  • AGF Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
  • AGF Management's Bristol-Myers Squibb position peaked at $44.9M in Q4 2022.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on AGF Management's 13F filing for Q1 2026, filed 7 May 2026.